Skip to main content

Follow us

Home

Search

the Gateway to Research in Oklahoma

  • Researchers
  • Providers
  • Patients
  • About GRO

Gateway to Research in Oklahoma


Oklahoma Shared Clinical and Translational Resources U54 GM104938

Researchers

imgResearchers

The GRO: Researcher Portal provides resources, information, and training to help individuals or communities involved in performing clinical and translational research in Oklahoma.

Providers

imgProviders

The GRO: Provider Portal assists medical providers to identify clinical research opportunities in Oklahoma, tools for patient education, and evidence-based resources to improve patient care.

Patients

imgPatients

The GRO: Patient Portal can help patients and families to learn more about clinical and translational research and to connect with opportunities to participate in research opportunities in your communities.

Oklahoma Research Highlights

Use of extracorporeal membrane oxygenation in neonates with congenital anomalies of the kidney and urinary tract: a multicenter survey of current practices across CHNC and Pedi-ECMO centers

2 days 14 hours ago
CONCLUSIONS: Variability among providers and institutes underscores the need for consensus-based guidelines to optimize decision-making and outcomes.
Syed Ahmed

Diminished variability of alpha and beta band-limited power as a neural signature in schizophrenia

2 days 14 hours ago
Spectral features of the electroencephalogram (EEG) are essential for providing clinically relevant biomarkers in schizophrenia (SZ). Despite literature indicating altered short-scale neural dynamics in SZ, however, band-limited power (BLP) indices are rarely assessed in a time-resolved manner. To address this, here we evaluated static and dynamic BLP indices in a sample of 30 SZ patients and 31 healthy control (HC) individuals. Guided by recent findings on power spectral dynamics in SZ, we...
Frigyes Samuel Racz

Precisely designed keystone metabolites boost shrimp disease resistance by recruiting symbionts via the lipoxin A4-AP-1 pathway

2 days 14 hours ago
CONCLUSIONS: Our findings demonstrate that precisely designed keystone metabolites enhance shrimp disease resistance through the recruitment of key symbionts-LXA4-AP-1 axis. The rationally designed keystone metabolites and SynCom are compelling biocontrol solutions in improving host disease resistance. Video Abstract.
Haonan Sha

Digital Mental Health: Progress but not Perfection

2 days 14 hours ago
No abstract
Caleb W Lack

Virtual Reality and Mental Health: A Review of Current Findings and Needed Expansions

2 days 14 hours ago
Virtual reality (VR) has generated growing enthusiasm as a tool to deliver evidence-based mental health treatments. By immersing individuals in interactive, simulated environments, VR allows for repeated exposure to feared stimuli, real-time practice, and clinician involvement. While the strongest evidence supports using VR exposure therapy for anxiety-related disorders, promising applications are emerging across a range of conditions. Despite promising findings, most studies have small samples...
J Kyle Haws

Pagination

  • Previous page ‹ Previous
  • Page 214
  • Next page Next ›
Subscribe to

octsi logo

1000 N. Lincoln Blvd, Suite 2100, Oklahoma City, OK 73104
Copyright © 2021 The Board of Regents of the University of Oklahoma, All Rights Reserved.

About GRO

News
Publications
FAQ

Terms of Use

Privacy Policy
Accessibility

Contact

info email
info phone
Copyright © 2026. All rights reserved. Designed By Zymphonies